Potential solutions include reducing dynamic range, volume reduction when not actively participating in the game, and actively reducing sounds that are known to induce tinnitus, or hearing ringing or buzzing sounds.
Seeing Friends at ARO in Anaheim
Palpable excitement was raised by reports from researchers who have recently published results of landmark gene therapy trials in young children targeting the otoferlin gene.
HHF Completes First Phase of Its Transformative Planned Giving Matching Challenge
The 218 planned gift commitments total an estimated $30 million to $50 million, 100 percent of which will be used to fund scientific research on hearing loss and related conditions.
Hearing When You Can’t Hear
A survey of more than 1,500 respondents with hearing loss found that while many look for and request accommodations, they are often not available—62 percent answered “seldom or never” when asked how often they can find accommodations.
Recruiting for a Gene Therapy Trial
Right now we are actively recruiting volunteers with hearing loss to participate in an outpatient research study to understand the genes that cause non-syndromic autosomal dominant hearing loss (DFNA).
We Are Proud of Our Charity Ratings
We know that these independent assessments of a nonprofit organization’s fiscal responsibility are important to donors who rely on them to evaluate where to allocate their dollars. We work hard to maintain these top marks.
Our Impact This Year, Thanks to You
We Are Filled With Gratitude This Thanksgiving
The entire team at Hearing Health Foundation, including our researchers, Board of Directors, scientific advisers, and staff, expresses our heartfelt appreciation to you for being a partner in hearing health.
Turning Down the Noise of Combat
Sound suppression technology is the latest innovation in military weaponry. While hearing protection is still a must, each bit of reduction is significant.
Emerging Research Grants: Call for Applications
The ERG program is a competitive process that awards grants to only the most promising investigators. Recipients are exceptionally well-positioned to win funding from major federal funders, with every $1 invested in ERG leading to an average of $56 in future funding.